Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shane M Devlin

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Inflammatory Bowel Diseases|August 1, 2007
Curry for the cure?Shane M Devlin
Inflammatory Bowel Diseases|January 25, 2012
Do thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease or is this an unanswerable question?Shane M Devlin
Expert Opinion on Biological Therapy|June 14, 2008
Adalimumab for the treatment of Crohn's diseaseShane M Devlin, Remo Panaccione
The Medical Clinics of North America|December 1, 2009
Evolving inflammatory bowel disease treatment paradigms: top-down versus step-upShane M Devlin, Remo Panaccione
Gastroenterology Clinics of North America|November 17, 2009
Evolving inflammatory bowel disease treatment paradigms: top-down versus step-upShane M Devlin, Remo Panaccione
Inflammatory Bowel Diseases|October 13, 2007
Determination of serologic and genetic markers aid in the determination of the clinical course and severity of patients with IBDShane M Devlin, Marla C Dubinsky
Digestive Diseases and Sciences|April 5, 2007
Mucormycosis presenting as recurrent gastric perforation in a patient with Crohn's disease on glucocorticoid, 6-mercaptopurine, and infliximab therapyShane M Devlin, Bing Hu, Andrew Ippoliti
Canadian Family Physician Medecin De Famille Canadien|June 3, 2004
Celiac disease. CME update for family physiciansShane M Devlin, Christopher N Andrews, Paul L Beck
Gastroenterology Clinics of North America|April 17, 2012
Patient-specific approach to combination versus monotherapy with the use of antitumor necrosis factor α agents for inflammatory bowel diseaseShane M Devlin, Adam S Cheifetz, Corey A Siegel, et al.
Therapeutic Advances in Gastroenterology|June 12, 2020
Complementary and alternative medications in the management of inflammatory bowel diseaseSherman Picardo, Mansour Altuwaijri, Shane M Devlin, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Inflammatory Bowel Diseases|August 1, 2007
Curry for the cure?Shane M Devlin
Inflammatory Bowel Diseases|January 25, 2012
Do thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease or is this an unanswerable question?Shane M Devlin
Expert Opinion on Biological Therapy|June 14, 2008
Adalimumab for the treatment of Crohn's diseaseShane M Devlin, Remo Panaccione
The Medical Clinics of North America|December 1, 2009
Evolving inflammatory bowel disease treatment paradigms: top-down versus step-upShane M Devlin, Remo Panaccione
Gastroenterology Clinics of North America|November 17, 2009
Evolving inflammatory bowel disease treatment paradigms: top-down versus step-upShane M Devlin, Remo Panaccione
Inflammatory Bowel Diseases|October 13, 2007
Determination of serologic and genetic markers aid in the determination of the clinical course and severity of patients with IBDShane M Devlin, Marla C Dubinsky
Digestive Diseases and Sciences|April 5, 2007
Mucormycosis presenting as recurrent gastric perforation in a patient with Crohn's disease on glucocorticoid, 6-mercaptopurine, and infliximab therapyShane M Devlin, Bing Hu, Andrew Ippoliti
Canadian Family Physician Medecin De Famille Canadien|June 3, 2004
Celiac disease. CME update for family physiciansShane M Devlin, Christopher N Andrews, Paul L Beck
Gastroenterology Clinics of North America|April 17, 2012
Patient-specific approach to combination versus monotherapy with the use of antitumor necrosis factor α agents for inflammatory bowel diseaseShane M Devlin, Adam S Cheifetz, Corey A Siegel, et al.
Therapeutic Advances in Gastroenterology|June 12, 2020
Complementary and alternative medications in the management of inflammatory bowel diseaseSherman Picardo, Mansour Altuwaijri, Shane M Devlin, et al.
Pageof 4